Evidence map›Paper›PMID 39295779›Full record

ReviewGut microbiome (Cambridge, England)2022

Microbial lactate utilisation and the stability of the gut microbiome.

Petra Louis, Sylvia Helen Duncan, Paul Owen Sheridan, Alan William Walker, Harry James Flint

Abstract readReview
In one paragraph

Review in Gut microbiome (Cambridge, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Extracellular metabolite production byApplied and environmental microbiology · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Acidification-dependent suppression ofInfection and immunity · 2026
    Article
  18. Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Petra LouisGut Health Group, Rowett Institute, University of Aberdeen, Aberdeen, UK.ORCID https://orcid.org/0000-0003-2115-2399
Sylvia Helen DuncanGut Health Group, Rowett Institute, University of Aberdeen, Aberdeen, UK.ORCID https://orcid.org/0000-0002-4903-0978
Paul Owen SheridanSchool of Biological Sciences, University of Aberdeen, Aberdeen, UK.ORCID https://orcid.org/0000-0001-8243-5718
Alan William WalkerGut Health Group, Rowett Institute, University of Aberdeen, Aberdeen, UK.ORCID https://orcid.org/0000-0001-5099-8495
Harry James FlintGut Health Group, Rowett Institute, University of Aberdeen, Aberdeen, UK.ORCID https://orcid.org/0000-0003-2116-0188

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human large intestinal microbiota thrives on dietary carbohydrates that are converted to a range of fermentation products. Short-chain fatty acids (acetate, propionate and butyrate) are the dominant fermentation acids that accumulate to high concentrations in the colon and they have health-promoting effects on the host. Although many gut microbes can also produce lactate, it usually does not accumulate in the healthy gut lumen. This appears largely to be due to the presence of a relatively small number of gut microbes that can utilise lactate and convert it to propionate, butyrate or acetate. There is increasing evidence that these microbes play important roles in maintaining a healthy gut environment. In this review, we will provide an overview of the different microbes involved in lactate metabolism within the gut microbiota, including biochemical pathways utilised and their underlying energetics, as well as regulation of the corresponding genes. We will further discuss the potential consequences of perturbation of the microbiota leading to lactate accumulation in the gut and associated disease states and how lactate-utilising bacteria may be employed to treat such diseases.

Indexed as

anaerobic fermentationcross-feedinggut microbiotalactateshortchain fatty acids

Identifiers

PMID39295779
PMCPMC11406415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.